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Type 2 diabetes (T2D) has become a serious 
public health problem throughout the world. 
Zimmet et al. (2001) estimated that approxi-
mately 150 million people worldwide had 
T2D in the year 2000, and they predicted 
that this number could double by 2025. In 
the United States alone, T2D affected > 7% 
of the population and resulted in an estimated 
$174 billion total annual economic cost in 
2007 (American Diabetes Association 2008). 
Obesity has been recognized as the leading 
cause of T2D, whereas many factors, includ-
ing genetic elements and lifestyle, are involved 
in the incidence of obesity. However, a link 
between environmental exposures and dia-
betes has also been established (Navas-Acien 
et al. 2008) but has received little attention 
by the medical community.
Arsenic is a naturally occurring element 
that is ubiquitous in the environment in both 
organic and inorganic forms (Nordstrom 
2002). Human exposure to the generally 
more toxic inorganic arsenic (iAs) occurs 
in occupational or environmental settings, 
as well as through medicinal arsenical use 
(Abernathy et al. 1999). The main source of 
human environ  mental exposure is through 
consumption of water containing elevated lev-
els of arsenic, primarily from natural contami-
nation (Gebel 1999). The U.S. Environmental 
Protection Agency set the arsenic standard for 
drinking water at 0.01 ppm in 2006. An esti-
mated 13 million Americans were exposed to 
higher levels of arsenic (> 0.01 ppm) through 
public water systems by 2006.
Chronic exposure to high levels of iAs is 
associated with a wide range of human ailments 
including cancer, arteriosclerosis, hypertension, 
and T2D. Although the evidence for a causal 
association between iAs exposure and T2D is 
not unequivocally established (Navas-Acien 
et al. 2006), epidemiological studies carried 
out in Taiwan (Chiu et al. 2006), Bangladesh 
(Nabi et al. 2005), Sweden (Rahman et al. 
1996), and Mexico (Coronado-Gonzalez et al. 
2007) have shown a strong diabetogenic effect 
of arsenic in humans. More recently, Meliker 
et al. (2007) reported a modest but significant 
association between iAs exposure and T2D in 
residents of Michigan, with average iAs level 
in drinking water of 0.011 ppm. In addition, a 
cross-sectional study carried out in 788 adults 
who partici  pated in the 2003–2004 National 
Health and Nutrition Examination Survey 
reveals a strong positive association between 
low-level arsenic exposure and the prevalence 
of T2D in the United States (Navas-Acien 
et al. 2008). These new epidemiological studies 
provided additional support for the impor-
tance of arsenic exposure in the develop  ment 
of T2D. Although the precise mechanisms for 
the diabetogenic effect of arsenic are still largely 
undefined, recent in vitro and in vivo experi-
mental studies indicated that iAs or its metabo-
lites impair insulin-dependent glucose uptake 
and result in insulin resistance (Izquierdo-Vega 
et al. 2006; Paul et al. 2007). In isolated rat 
islets, iAs decreased insulin transcription and 
secretion (Diaz-Villasenor et al. 2006).
A key driver in the pathogenesis of T2D 
is the impairment of pancreatic β-cell func-
tion, with the hallmark of β-cell function being 
glucose-stimulated insulin secretion (GSIS) 
(Fridlyand and Philipson 2004). According to 
the currently accepted hypothesis, the control 
of GSIS in β cells depends largely on glucose 
metabolism, in which glycolytic and oxidative 
phosphorylation triggers a sequence of signaling 
events, including increased ATP production 
and ATP/ADP ratio, leading to insulin secre-
tion (Henquin 2004; Newgard and McGarry 
1995). Emerging evidence—including our 
own (Pi et al. 2007)—suggests that, in addi-
tion to ATP and ATP/ADP ratio, reactive 
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Ba c k g r o u n d: Chronic exposure of humans to inorganic arsenic, a potent environmental oxidative 
stressor, is associated with incidence of type 2 diabetes (T2D). A key driver in the pathogenesis of 
T2D is impairment of pancreatic β-cell function, with the hallmark of β-cell function being glucose-
stimulated insulin secretion (GSIS). Reactive oxygen species (ROS) derived from glucose metabolism 
serve as one of the metabolic signals for GSIS. Nuclear factor-erythroid 2–related factor 2 (Nrf2) is a 
central transcription factor regulating cellular adaptive response to oxidative stress.
oBjectives: We tested the hypothesis that activation of Nrf2 and induction of antioxidant enzymes 
in response to arsenic exposure impedes glucose-triggered ROS signaling and thus GSIS.
Me t h o d s  a n d r e s u l t s: Exposure of INS-1(832/13) cells to low levels of arsenite led to decreased 
GSIS in a dose- and time-dependent fashion. Consistent with our hypothesis, a significantly 
enhanced Nrf2 activity, determined by its nuclear accumulation and induction of its target genes, 
was observed in arsenite-exposed cells. In keeping with the activation of Nrf2-mediated antioxidant 
response, intracellular glutathione and intracellular hydrogen peroxide–scavenging activity was dose 
dependently increased by arsenite exposure. Although the basal cellular peroxide level was signifi-
cantly enhanced, the net percentage increase in glucose-stimulated intracellular peroxide production 
was markedly inhibited in arsenite-exposed cells. In contrast, insulin synthesis and the consensus 
GSIS pathway, including glucose transport and metabolism, were not significantly reduced by 
arsenite exposure.
co n c l u s i o n s: Our studies suggest that low levels of arsenic provoke a cellular adaptive oxidative 
stress response that increases antioxidant levels, dampens ROS signaling involved in GSIS, and thus 
disturbs β-cell function.
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oxygen species (ROS), such as hydrogen perox-
ide (H2O2), derived from glucose metabolism 
serve as one of the metabolic signals for GSIS. 
Thus, endogenous anti  oxidant enzymes that 
can be robustly induced in response to oxidative 
stress have the potential to blunt such a glucose-
triggered ROS signal and inhibit GSIS (Pi et al. 
2010; Zhang et al. 2010).
Accumulating data, including our pre-
vious studies (Pi et al. 2003a, 2003b), sug-
gest that arsenic exposure is associated with 
increased oxidative stress, which has been 
undisputedly implicated in the etiology of 
T2D. A key cellular component that defends 
cells against oxidative damage is nuclear 
factor-erythroid 2–related factor 2 (Nrf2), a 
transcription factor that regulates both con-
stitutive and inducible expression of many 
antioxidant/detoxification enzymes (Kobayashi 
and Yamamoto 2006). However, this same 
Nrf2-driven induction of endogenous anti-
oxidant enzymes, meant to maintain intra-
cellular redox homeo  stasis and limit oxidative 
damage, may also have the potential, as a side 
effect, to diminish ROS that function as intra-
cellular signals (Pi et al. 2010; Zhang et al. 
2010). Here we report that low levels of arsen-
ite trigger a cellular adaptive oxidative stress 
response and impair ROS signaling involved in 
GSIS, thus disturbing β-cell function.
Materials and Methods
Cell culture and reagents. INS-1(832/13) cells 
were kindly provided by C. Newgard (Duke 
University, Durham, NC, USA) and were cul-
tured in RPMI medium 1640 supplemented 
with 10% fetal bovine serum (FBS), 10 mM 
glucose, 25 mM HEPES, 2 mM l-glutamine, 
50 µM β-mercaptoethanol, 100 U penicillin/
mL, and 100 µg streptomycin/mL. Cultures 
were maintained at 37°C in a humidified 5% 
CO2 atmosphere. We used passages 55–59 at 
75–90% confluence for the present study; there 
was no difference in the glucose responsiveness 
of the cells among passages 55, 56, 57, 58, and 
59. Culture media, FBS, and supplements were 
purchased from Invitrogen (Carlsbad, CA, 
USA). Sodium arsenite, fatty acid–free bovine 
serum albumin (BSA), β-mercaptoethanol, and 
glucose solution (45%) were obtained from 
Sigma (St. Louis, MO, USA).
Measurement of insulin secretion. 
Experiments were performed in static incuba-
tion as described previously (Pi et al. 2007). 
Levels of secreted insulin were normalized to 
DNA content, which was determined by an 
overnight incubation at 37°C with a lysis buffer 
containing 30 mM Tris-HCl, 10 mM EDTA, 
1% sodium dodecyl sulfate, and 50 µg/mL 
proteinase K (Qiagen, Valencia, CA, USA), 
followed by a measurement of absorbance at 
260 nm using a Nanodrop spectrophotometer 
(Thermo Scientific, Inc., Wilmington, DE, 
USA). Insulin measurements were determined 
using a radio  immuno  assay kit (Linco Research, 
St. Charles, MO, USA) with rat insulin as the 
standard.
Antioxidant response element (ARE) 
reporter assay. Cignal Lenti ARE reporter lenti-
viral particles were obtained from SABiosciences 
(Frederick, MD, USA). Lentiviral transduc-
tion of INS-1(832/13) cells was performed 
as described previously (Woods et al. 2009). 
Cells were grown to approximately 90% con-
fluency and subcultured in medium contain-
ing 0.35 µg/mL puromycin. We measured 
luciferase activity using the Dual-Luciferase 
Reporter Assay System (Promega, Madison, 
WI, USA) according to the manufacturer’s 
protocol. The luciferase activity was normalized 
to cell viability, which was determined using a 
Non-Radioactive Cell-Proliferation Assay Kit 
(Promega).
Intracellular peroxide determination. 
Intracellular peroxide levels were mea-
sured by flow cytometry (FACSort; Becton 
Dickinson, San Jose, CA, USA) using the 
fluorescent probe 5-(and-6)-chloro  methyl-2´, 
7´-dichlorodihydro  fluorescein diacetate, acetyl 
ester (Molecular Probes, Eugene, OR, USA) 
as described previously (Pi et al. 2007).
Measurement of intracellular glutathi-
one (GSH). Cells were sonicated in cold 
phosphate-buffered saline (PBS) immediately 
after collection, followed by centrifugation 
at 12,000 × g for 5 min. The resulting super-
natants were used for measurement of oxi-
dized GSH (GSSG) and total GSH. Samples 
for GSSG measurement were immediately 
mixed with thiol-scavenging reagent M2VP 
(1-methyl-2-vinyl-pyridium trifluoromethane 
sulfonate) after separation. Levels of total 
GSH (intra  cellular GSH + GSSG) and GSSG 
in cells were measured immediately after col-
lection using the BIOXYTECH GSH/GSSG-
412 kit (OxisResearch, Portland, OR, USA) 
according to the manufacturer’s protocols. 
The concentrations of intra  cellular GSH were 
calculated by the equation 
  Intra  cellular GSH =  
    total GSH – (2 × GSSG).
Measurement of H2O2-scavenging activity.   
Cells were washed three times with ice-
cold PBS and lysed in the same with 0.5% 
Protease Inhibitor Cocktail (Sigma) by sonica-
tion, followed by centrifugation at 12,000 × g 
for 5 min. The resulting supernatants were 
used immediately for measurement of H2O2-
scavenging activity as described previously 
(Pi et al. 2009). Briefly, up to 100 µmol/L 
of H2O2 in PBS were incubated with the 
cell lysates (2 µg protein/µL) for 30 min. 
The H2O2 remaining in the solutions was 
measured using the Amplex Red Hydrogen 
Peroxide Assay Kit (Invitrogen). The dif-
ference in H2O2 concentrations between 
lysate-treated and PBS control represents the 
H2O2-scavenging activity contributed by cells. 
Protein concentrations were determined by 
the Bio-Rad protein assay (Bio-Rad, Hercules, 
CA, USA) using BSA as a standard.
Quantitative real-time reverse-transcriptase 
polymerase chain reaction (RT-PCR) analy-
sis. Total RNA was isolated with TRIzol 
(Invitrogen), then subjected to cleanup using 
RNase-Free DNase Set and the RNeasy Mini 
kit (Qiagen). Quantitative real-time RT-PCR 
was performed as described previously 
(Woods et al. 2009). The primers (sequences 
are shown in Supplemental Material, 
Table S1 (doi:10.1289/ehp.0901608) were 
designed using Primer Express 3 (Applied 
Biosystems, Carlsbad, CA, USA) and synthe-
sized by MWG-BIOTECH Inc. (High Point, 
NC, USA). Real-time fluorescence detection 
was carried out using an ABI PRISM 7900 
Sequence Detector (Applied Biosystems).
Western blot analysis. Isolation of cell frac-
tions and Western blotting was performed as 
detailed previously (Pi et al. 2003b; Woods 
et al. 2009). We obtained antibodies for Nrf2 
(sc-13032; 1:500), gluco  kinase (GCK; sc-7908; 
1:1000), glucose transporter 2 (Glut2, sc-9117; 
1:1000), potassium inwardly rectifying chan-
nel, subfamily J, member 11 (KCNJ11, also 
termed KIR6.2; sc-11226; 1:500), sulfonyl-
urea receptor 1 (SUR1; sc-25683; 1:1000), and 
p68 Src-associated protein in mitosis (SAM68; 
sc-333; 1:500) from Santa Cruz Biotechnology 
Inc. (Santa Cruz, CA, USA). Antibodies for 
lamin A (L1293; 1:2500) and β-actin (A1978; 
1:2000) were purchased from Sigma.
Measurements of mitochondrial mass. 
We determined mitochondrial mass by flow 
cytometry (FACSort) and confocal microscope 
using the fluorescent probe MitoTracker green 
(Molecular Probes). The final concentration of 
the probe used was 75 nM, and the preload-
ing time was 30 min. In the flow cytometry 
measurements, dead cells and clumps were 
eliminated based on forward scatter versus side 
scatter measurement, and untreated cells pro-
vided a source of comparison. We obtained 
the fluorescence images using a laser scan-
ning confocal microscope (LSM 510 Meta) 
mounted on an Axiovert 100M microscope 
(Carl Zeiss, Inc., Thornwood, NY, USA), 
using a 488-nm laser for excitation and an 
LP 505 filter for emission. For acquisition, we 
used Zeiss LSM510 software, version 4.2 SP1 
for Windows 2000.
Oxygen consumption rate (OCR). OCR 
was measured by the XF24 Extracellular Flux 
Analyzer (Seahorse Bioscience, Billerica, MA, 
USA) as described previously (Wu et al. 2007).
Measurement of ATP. Cells were washed 
three times with ice-cold Kreb’s buffer with the 
same concentrations of glucose as treatments 
and lysed in ATP-releasing buffer (Sigma), 
followed by centrifugation at 12,000 × g for Fu et al.
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5 min. The resulting super  natants were used 
immediately for measurement of ATP using 
an ATP Bioluminescent Assay Kit (Sigma).
Statistical analyses. All statistical analy-
ses were performed using Graphpad Prism 4 
(GraphPad Software, San Diego, CA, USA), 
with p < 0.05 taken as significant. More spe-
cific indices of statistical significance are indi-
cated in individual figure legends. Data are 
expressed as mean ± SE. For comparisons 
among groups, we performed one-way analysis 
of variance with Bonferroni post hoc testing. 
Results
Prolonged arsenite exposure inhibits GSIS in 
pancreatic β cells. INS-1(832/13) cells are 
highly responsive to increasing glucose con-
centrations and have been used widely to eval-
uate mechanisms of GSIS in vitro (Newgard 
et al. 2002; Pi et al. 2007). As shown in 
Figure 1A, exposure of INS-1(832/13) cells 
to arsenite at non  cytotoxic concentrations [see 
Supplemental Material, Figure 1 (doi:10.1289/
ehp.0901608)] for 96 hr resulted in a dose-
dependent reduction in insulin secretion in 
response to glucose stimulation, whereas potas-
sium chloride (KCl), which leads directly to 
cell membrane depolarization and opening of 
voltage-operated Ca2+ channels, caused a sig-
nificant increase of insulin release (Figure 1A) 
in the cells treated with 0.5 µM arsenite. These 
results are quite intriguing in that they are 
highly consistent with our previous data show-
ing a markedly blunted insulin secretion from 
these cells and from mouse islets after a shorter 
time of exposure (6–24 hr) to arsenite (Pi 
et al. 2007) [see also Supplemental Material, 
Figure 2 (doi:10.1289/ehp.0901608)]. In 
contrast to the decreased GSIS, basal insu-
lin release was elevated (in the presence of 
3 mM glucose) in the arsenite-treated cells 
(Figure 1A). This result is likely due, at least 
in part, to the increase in gene expression 
(Figure 1B) and protein levels (Figure 1C) 
of insulin in the cells. It should be noted 
that INS-1(832/13) cells have been stably 
transfected with gene encoding for human 
pro  insulin and selected for the most robust 
response to glucose (Hohmeier et al. 2000).
Arsenite activates the Nrf2-mediated 
anti  oxidant response. To determine whether 
prolonged arsenite exposure activates the Nrf2-
mediated antioxidant response, we measured 
nuclear accumulation of Nrf2 protein, activity 
of ARE-luciferase reporter, and induction of 
Nrf2 target genes in the arsenite-exposed cells. 
As shown in Figure 2A, 96-hr arsenite exposure 
markedly increased the protein levels of Nrf2 in 
nuclear fractions in a dose-dependent fashion. 
The Cignal Lenti ARE reporter is designed to 
monitor the activity of the anti  xidant response 
signal transduction pathway in cultured cells. 
INS-1(832/13) cells stably transduced with 
the Cignal Lenti ARE reporter showed dose-
dependent induction of luciferase activity after 
sulfora  phane and tert-butylhydroquinone treat-
ment [see Supplemental Material, Figure 3 
(doi:10.1289/ehp.0901608)], confirming that 
the cells are responsive to Nrf2 activation. 
We next examined the ARE activity induced 
by arsenite. After the ARE reporter cells were 
exposed to arsenite for 96 hr, we observed a 
dose-dependent increase in ARE-luciferase 
activity (Figure 2B). Consistent with the ARE-
reporter assay, expression of many Nrf2-target 
genes such as heme oxygenase 1 (Hmox1), 
NAD(P)H: quinone oxidoreductase 1 (Nqo1), 
catalase (Cat), γ-glutamate cysteine ligase 
cata  lytic subunit (Gclc) and regulatory sub-
unit (Gclm), and sulfi  redoxin 1 (Srxn1) were 
significantly induced (Figure 2C), whereas 
some genes, including adenine nucleotide 
translocator (Ant), were unaffected (see 
Supplemental Material, Figure 4). The accu-
mulation of Nrf2 in nuclear fractions, activa-
tion of ARE reporter, and significant induction 
of Nrf2-target genes indicate an activation of 
Nrf2-mediated adaptive response in the arsenite- 
exposed cells.
Arsenite exposure decreases glucose-
stimulated peroxide accumulation. GSH is 
the most important, as well as most abun-
dant, redox buffer in cells (Jones 2002). In 
its reaction to scavenge peroxides, GSH is 
converted by oxidation to GSSG. This dis-
ulfide can be reduced back to GSH by glu-
tathione reductase. In keeping with the 
activation of Nrf2-mediated antioxidant 
response, evidenced by enhanced expression 
of Nrf2-target genes (Figure 2C), intra  cellular 
GSH (Figure 3A) and intra  cellular H2O2-
scavenging activity (Figure 3B) were dose 
dependently increased by arsenite exposure. 
However, we found no enhanced GSSG level 
in the arsenite-treated cells (data not shown). 
In the presence of 3 mM glucose, the basal 
intra  cellular peroxide level was significantly 
increased by arsenite exposure (Figure 3C), 
which may have contributed to the increased 
basal insulin secretion (Figure 1A). In contrast 
to the enhanced basal intra  cellular peroxide 
level, the net percentage increase in glucose-
stimulated intra  cellular peroxide production 
was markedly inhibited in arsenite-exposed 
cells (Figure 3D), which are positively corre-
lated with their decreased GSIS (Figure 1A). 
These findings suggest that arsenite-induced 
oxidative stress triggers cellular adaptive 
responses, including Nrf2 activation and 
subsequent enhancement in cellu  lar H2O2-
scavenging activity, which might dampen 
glucose-triggered ROS signaling that medi-
ates GSIS. Consistent with this notion, 
INS-1(832/13) cells challenged with another 
Nrf2 activator, sulforaphane, or over  expressed 
Nrf2 exhibit a modest but significant decrease 
in GSIS [see Supplemental Material, Figure 5 
(doi:10.1289/ehp.0901608)].
Figure 1. Effect of prolonged arsenite exposure on GSIS in INS‑1(832/13) cells. (A) Insulin secretion triggered 
by glucose or KCl measured immediately after a 96‑hr arsenite exposure. The level of secreted insulin was 
normalized by DNA content and expressed as a percentage of control (no arsenite) plus 3 mM glucose; insu‑
lin secreted at the 3‑mM glucose condition was 0.25 ± 0.06 µg/mg DNA/30 min. The ratio represents insulin 
secreted at a dose of 20 mM glucose divided by that at 3 mM glucose. Values shown are mean ± SE of two to 
five independent experiments. (B) Gene expression of insulin (cycle threshold value of control = 14). (C) Insulin 
content in whole‑cell lysates normalized by DNA content and expressed as the percentage of control 
(54.0 ± 3.4 µg/mg DNA).
*p < 0.05 vs. control plus 3 mM glucose. **p < 0.05 vs. control plus 20 mM glucose. #p < 0.05 vs. ratio of control. ##p < 0.05 
vs. control plus KCl. 
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Effects of arsenite exposure on the consensus   
GSIS pathway. The relationship between glu-
cose stimulation and insulin secretion from the 
pancreatic β cells is linked with glucose uptake 
and metabolism as well as with ATP produc-
tion. In contrast to the dramatic decrease of 
GSIS in arsenite-exposed INS-1(832/13) cells, 
no decreased gene and protein expression of 
major glucose transporter Glut2 and metabo-
lism enzyme Gck was observed (Figure 4A,B). 
In the consensus model of GSIS, the ATP-
sensitive potassium (KATP) channel is an 
important component in the pathway. The 
KATP channel is composed of four units of 
inwardly rectifying K channel subunit KIR6.2, 
which is encoded by the Kcnj11 gene, and 
four copies of regulatory subunit SUR1 in an 
octameric complex. SUR1 is a member of the 
ATP-binding cassette super family. SUR recep-
tor confers the sensitivity of KIR6.2 to ATP/
ADP and to pharmacological agents, such as 
sulfonyl  urea and diazoxide, that close or open 
the KATP channels (Henquin 2000; Wollheim 
and Maechler 2002). In the present study, 
the gene and protein expressions of SUR1 
and KIR6.2 showed no significant decrease 
in the arsenite-exposed cells (Figure 4A,B), 
although the activity of the KATP channel was 
not directly determined. ATP production is 
the primary regulator of KATP; thus, the ATP 
levels under low- and high-glucose conditions 
were determined in the arsenite-exposed cells. 
However, no decrease in glucose-stimulated 
ATP production was observed in the cells 
(Figure 4C). Mitochondria have been recog-
nized as some of the most important organelles 
that regulate GSIS in pancreatic β cells. In 
contrast to the significant reduction in GSIS, 
arsenite exposure did not decrease, but dose 
dependently enhanced, mitochondrial mass 
(Figure 5A–C). Consistent with this find-
ing, OCR under basal condition (in the pres-
ence of 3 mM glucose) was dose dependently 
increased by arsenite exposure (Figure 5D), 
although 20 mM glucose-stimulated OCR 
seemed to show a dose-dependent decrease. 
The results of these experiments suggest that 
the impaired GSIS of INS-1(832/13) cells 
caused by prolonged arsenite exposure is not 
associated with the consensus GSIS pathway.
Discussion
The development of T2D is usually associated 
with a combination of β-cell dysfunction and 
insulin resistance. Normal healthy β cells can 
compensate for insulin resistance by increasing 
insulin secretion or β-cell mass. Insufficient 
compensation ultimately leads to the onset of 
glucose intolerance and T2D (Kajimoto and 
Kaneto 2004). Although the precise molecular 
mechanisms of β-cell dysfunction in T2D are 
not completely understood, oxidative stress 
has been increasingly implicated in the patho-
genesis of progressive β-cell failure (Kajimoto 
Figure 2. Nrf2‑mediated antioxidant response in INS‑1(832/13) cells exposed to arsenite for 96 hr. (A) 
Western blot of Nrf2 in isolated nuclear fractions, with lamin A as a loading control. (B) Activity of ARE‑
luciferase reporter. (C) Expression of Nrf2‑target genes measured by qRT‑PCR. The cycle threshold value of 
that gene in control cells is shown in parentheses after the gene name; n = 2–5 independent experiments. 
*p < 0.05 vs. control.
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Figure 3. Effect of prolonged arsenite exposure on H2O2‑scavenging activity and glucose‑stimulated 
peroxide production in INS‑1(832/13) cells. (A) Arsenite increases intracellular GSH levels; GSH levels in 
whole cell lysates were normalized to protein content and expressed as a percentage of control (54.0 ± 1.7 
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*p < 0.05 compared with control.
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and Kaneto 2004; Robertson and Harmon 
2006). Our previous studies provided evi-
dence that H2O2 derived from glucose 
metabolism is one of the metabolic signals for 
insulin secretion (Pi et al. 2007). In contrast, 
endogenous antioxidant enzymes that can 
be induced by various oxidative stress con-
ditions may function as negative regulators 
for ROS signaling and thus GSIS (Pi et al. 
2010; Zhang et al. 2010). In this study, pro-
longed exposure of INS-1(832/13) cells to 
low levels of arsenite led to decreased GSIS 
in a dose-dependent manner. Consistent with 
this hypothesis, intra  cellular GSH and H2O2-
scavenging activity were significantly increased 
in the arsenite-treated cells. The increased 
antioxidant activity significantly inhibited net 
glucose-stimulated intracellular peroxide pro-
duction, which is involved in GSIS. These 
studies suggest that low levels of arsenic trig-
ger a cellular adaptive response, which impairs 
ROS signaling involved in GSIS, and thus 
disturbs β-cell function (Figure 6).
Cellular metabolism is the process of sub-
strate uptake (oxygen, glucose, fatty acids) and 
energy conversion through a series of enzymati-
cally controlled oxidation/reduction reactions. 
These reactions are executed through a series of 
intracellular biochemical processes (glycolysis, 
Krebs cycle, electron transport, and oxidative 
phosphorylation) resulting in the production 
of ATP and the release of heat and chemical 
by-products (lactate and CO2) into the extra-
cellular environment (Wu et al. 2007). GSIS 
is regulated by the rate of glucose metabolism 
within β-cells. After its initial uptake and phos-
phorylation, glucose metabolism involves both 
cytosolic and mitochondrial processes and 
generates signals leading to insulin secretion 
(Newgard and McGarry 1995). It has become 
established in the field that glycolytic and oxi-
dative processes leading to an increased ATP/
ADP ratio are key transduction events in β-cell 
signaling. However, the precise signals that 
couple glucose catabolism to insulin secretion 
are still incompletely understood. The consen-
sus model explaining how glucose generates 
a triggering signal in β cells involves the fol-
lowing sequence of events: entry of glucose by 
facilitated diffusion into the cell, metabolism 
by oxidative glycolysis, rise in ATP/ADP ratio, 
closure of KATP channels, depolarization of the 
plasma membrane potential, opening of volt-
age-operated Ca2+ channels, influx of Ca2+, rise 
in cytosolic Ca2+, and activation of exo  cytotic 
machinery for release of insulin (Henquin 
2000). Improper function of any of these 
components can impair GSIS. However, in 
the present study, we found no clear evidence 
that the consensus GSIS pathway, including 
expression of Glut2, Gck, and KATP, and glu-
cose-stimulated ATP production, is affected 
by arsenite exposure, suggesting that a differ-
ent mechanism is involved in the impairment. 
Mitochondria are important organelles that 
regulate GSIS in pancreatic β cells. However, 
arsenite exposure did not decrease—but dose 
dependently enhanced—mitochondrial mass. 
This finding further suggests that the decreased 
GSIS caused by prolonged arsenite exposure is 
unlikely related to the impairment of the con-
sensus GSIS pathway. It should be noted that 
Figure 4. Effect of prolonged arsenite exposure on the classic GSIS pathway. Expression of genes (A) and 
proteins (B) in INS‑1(832/13) cells exposed to arsenite for 96 hr, measured by qRT‑PCR and Western blot‑
ting, respectively. The cycle threshold value of that gene in control cells is shown in parentheses after the 
gene name. (C) ATP levels under low and high glucose conditions; values are expressed as a percentage 
of control cells with low (3 mM) glucose, which was determined as 310.9 ± 9.8 nmol/mg DNA. Data in A–C 
represent three independent experiments.
*p < 0.05 compared with control (A) or 3 mM glucose in the same cells (C).
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arsenate may uncouple mitochondrial oxidative 
phosphorylation and decrease ATP generation 
and thus has the potential to directly impair 
GSIS. However, the concentration required 
is much higher than environmentally relevant 
levels (Tseng 2004). Importantly, in the cur-
rent study no reduction in ATP production 
was observed in the arsenite-treated cells.
ROS clearly possess the capacity to 
behave in a random and destructive fashion 
and can directly or indirectly disturb physi-
ological functions of many cellular macro-
molecules such as DNA, protein, and lipids, 
and activate cellular stress-sensitive signal-
ing pathways. Having evolved in an oxy-
gen environment, most cells have acquired 
intricate defense mechanisms to counteract 
oxidative stress and defend against ROS tox-
icity. Among them, induction of a family 
of antioxidant/detoxification enzymes that 
enhance cellular ROS-scavenging capacity is 
a key element in the maintenance of cellu  lar 
redox homeostasis and in reducing oxidative 
damage (Kobayashi and Yamamoto 2006). 
Accumulating data indicate that these antioxi-
dant genes are coordinately regulated through 
consensus elements called AREs in their 
5´-flanking promoter regions (Nguyen et al. 
2003). Nrf2, a member of the bZIP family of 
transcription factors, is a central regulator of 
both constitutive and inducible ARE-related 
gene expression (Itoh et al. 2004). Supporting 
its importance in antioxidant response is the 
finding that Nrf2-knockout mice show a defi-
ciency in this coordinated gene regulatory 
program and have a higher susceptibility to 
oxidative damage and chemical carcinogen-
esis. Thus, the Nrf2-mediated antioxidant 
response represents a critically important cel-
lular defense mechanism that serves to main-
tain intra  cellular redox homeostasis and limit 
oxidative damage (Itoh et al. 2004; Nguyen 
et al. 2003). In spite of this protective role, 
the Nrf2-mediated anti  oxidant response has 
the potential to bring an undesirable effect. In 
the case where ROS serves as a signal, it could 
dampen such a signal triggered, for instance, 
by glucose oxidation. Therefore, we propose 
that Nrf2-mediated antioxidant response plays 
a paradoxical role in insulin secretion (Pi et al. 
2010). On one hand, it protects β cells from 
oxidative damage and possible cell death, 
thus minimizing oxidative damage-related 
impairment of insulin secretion. On the other 
hand, because ROS signaling triggered by 
glucose could be an important component of 
the machinery of insulin secretion, the induc-
tion of endogenous antioxidants in the pres-
ence of oxidative stress may blunt this signal, 
resulting in reduced GSIS (Figure 6). We 
envisage the following scenarios for arsenic- 
induced impairment of β-cell function. Under 
low-level oxidative stress, such as low-dose 
arsenite exposure, β cells can adapt to the 
condition adequately by activating the Nrf2-
ARE system, thereby keeping oxidative dam-
age/cell death-related impairment of GSIS 
at a minimum. However, on a chronic basis, 
an increase in the level of endogenous anti-
oxidants may interfere with glucose-dependent   
ROS signals that we postulate directly con-
tribute to GSIS. Under excessive oxidative 
stress or high dose of arsenic exposure, the 
Nrf2 system may be overwhelmed and unable 
to adequately compensate, resulting in irre-
versible oxidative damage. In this situa  tion, 
excessive oxidative damage and possible 
cell death become the primary cause for the 
impaired GSIS; thus, the machinery of GSIS 
in β cells is likely to be critically sensitive to 
all levels of arsenic. These considerations are 
compatible with the view that oxidative stress 
may contribute to both early and late phases 
of β-cell failure in T2D.
Taken together, our data indicate that 
low concentrations of arsenite cause oxidative 
stress and cellular adaptive response, including 
Nrf2 activation, in β cells, and such a cellular 
adaptive response to arsenite is associated with 
impairment of GSIS. Although the etiology 
of T2D is still unclear to date, therapeutic 
approaches have focused on medication and 
lifestyle modification. The role of environ-
mental exposures must also be considered in 
the future.
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